These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 685927)

  • 1. Clofibrate therapy and gallstone induction.
    Bateson MC; Maclean D; Ross PE; Bouchier IA
    Am J Dig Dis; 1978 Jul; 23(7):623-8. PubMed ID: 685927
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of gemfibrozil administration on biliary lipid secretion in hyperlipidemic patients. A crossover study with clofibrate.
    Mazzella G; Bazzoli F; Villanova N; Simoni P; Festi D; Roda A; Aldini R; Roda E
    Scand J Gastroenterol; 1990 Dec; 25(12):1227-34. PubMed ID: 2274744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
    Grundy SM; Mok HY
    J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cholesterolic gallstones. Pathophysiology and treatment (author's transl)].
    Heller F; Harvengt C
    Acta Gastroenterol Belg; 1977; 40(11-12):392-405. PubMed ID: 347866
    [No Abstract]   [Full Text] [Related]  

  • 5. Bile compositional changes and cholesterol stone formation following orthotopic liver transplantation.
    Farouk M; Branum GD; Watters CR; Cucchiaro G; Helms M; McCann R; Bollinger R; Meyers WC
    Transplantation; 1991 Oct; 52(4):727-30. PubMed ID: 1926353
    [No Abstract]   [Full Text] [Related]  

  • 6. Bile acid metabolism in cirrhosis. 3. Biliary lipid secretion in patients with cirrhosis and its relevance to gallstone formation.
    Vlahcevic ZR; Yoshida T; Juttijudata P; Bell CC; Swell L
    Gastroenterology; 1973 Feb; 64(2):298-303. PubMed ID: 4686338
    [No Abstract]   [Full Text] [Related]  

  • 7. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of ursodeoxycholic acid on bile supersaturated with cholesterol in patients pretreated with clofibrate.
    Kutz K; Schulte A
    Z Gastroenterol; 1981 May; 19(5):231-6. PubMed ID: 7257479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.
    Kutz K; Schulte A; Just C; Lindstaedt H; Reiter B
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):171-7. PubMed ID: 503248
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Clofibrate and gallstones.
    Cooper J; Geizerova H; Oliver MF
    Lancet; 1975 May; 1(7915):1083. PubMed ID: 48743
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship of bile acid pool size to biliary lipid excretion and the formation of lithogenic bile in man.
    Swell L; Bell CC; Vlahcevic ZR
    Gastroenterology; 1971 Nov; 61(5):716-22. PubMed ID: 5117636
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.
    Bateson MC; Ross PE; Murison J; Bouchier IA
    Br Med J; 1978 May; 1(6121):1171-3. PubMed ID: 638677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cholesterol gallstones formation.
    Grundy SM
    Semin Liver Dis; 1983 May; 3(2):97-111. PubMed ID: 6683429
    [No Abstract]   [Full Text] [Related]  

  • 15. Some aspects of gallstone: a clinico-biochemical correlation.
    Hamid MA
    West Afr J Pharmacol Drug Res; 1975 Jun; 2(1):38-47. PubMed ID: 1226731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demonstration of the role of cholelithiasis in the onset of acute pancreatitis occurring during clofibrate (or its analog) treatment of atherogenic hyperlipemia].
    De Gennes JL; Dairou F; Surbled-Delas B
    Ann Med Interne (Paris); 1978; 129(6-7):435-9. PubMed ID: 686580
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia.
    Podda M; Zuin M
    Atherosclerosis; 1985 May; 55(2):135-42. PubMed ID: 4004987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fenofibrate on bile lipid composition.
    Palmer RH
    Arteriosclerosis; 1985; 5(6):631-8. PubMed ID: 4074196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary lipid outputs in young women with cholesterol gallstones.
    Grundy SM; Duane WC; Adler RD; Aron JM; Metzger AL
    Metabolism; 1974 Jan; 23(1):67-73. PubMed ID: 4808513
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clofibrate therapy--the status quo].
    Reuter W
    Z Gesamte Inn Med; 1982 Jan; 37(2):59-63. PubMed ID: 7080553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.